Clinicopathologic understanding and control of varicella-zoster virus infection

Vaccine

Volumn 26, Issue 50, 2008, Pages 6487-6490

  Asano, Yoshizo ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acyclovir; Herpes zoster; Varicella; Varicella vaccine; Varicella zoster virus; VZV skin test

Indexed keywords

ACICLOVIR; LIVE VACCINE; VARICELLA ZOSTER VACCINE; VIRUS DNA;

ARTICLE; CELLULAR IMMUNITY; DELAYED HYPERSENSITIVITY; DRUG EFFICACY; DRUG TOLERABILITY; HEALTH CARE DISTRIBUTION; HERPES ZOSTER; HUMAN; IMMUNOGENICITY; INCUBATION TIME; INFECTION CONTROL; INFECTION PREVENTION; INFECTION SENSITIVITY; LOW TEMPERATURE; MASS IMMUNIZATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SKIN TEST; VARICELLA ZOSTER VIRUS; VIRUS IMMUNITY; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ACYCLOVIR; ANTIVIRAL AGENTS; CHICKENPOX; CHICKENPOX VACCINE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; SKIN TESTS;

EID: 55749102262     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.08.004     Document Type: Article

References (48)

1. Takahashi M., Otsuka T., Okuno T., Asano Y., Yazaki T., and Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet ii (1974) 1288-1290
2. Asano Y., Yazaki T., Miyata T., Nakayama H., Hirose S., Ito S., et al. Application of a live varicella vaccine to hospitalized children and its protective effect on spread of varicella infection. Biken J 18 (1975) 35-40
3. Asano Y., Yazaki T., Ito S., Isomura S., and Takahashi M. Contact infection from varicella vaccine recipients. Lancet I (1976) 965
4. Asano Y., Nakayama H., Yazaki T., Kato R., Hirose S., Tsuzuki K., et al. Protection of varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics 59 (1977) 3-7
5. Asano Y., Nakayama H., Yazaki T., Ito S., Isomura S., and Takahashi M. Protective efficacy of vaccination in children in four episodes of natural varicella and zoster in the ward. Pediatrics 59 (1977) 8-12
6. Asano Y., and Takahashi M. Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children. Pediatrics 60 (1977) 810-814
7. Asano Y., and Takahashi M. Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster. Biken J 21 (1978) 15-23
8. Ozaki T., Nagayoshi S., Morishima T., Isomura S., Suzuki S., Asano Y., et al. Use of live varicella vaccine for acute leukemic children shortly after exposure in a children's word. Biken J 21 (1978) 69-72
9. Asano Y., Iwayama S., Miyata T., Yazaki T., Ozaki T., Tsuzuki K., et al. Spread of varicella in hospitalized children having no direct contact with an indicator zoster case and its prevention by a live vaccine. Biken J 23 (1980) 157-161
10. Asano Y., Hirose S., Iwayama S., Miyata T., Yazaki T., and Takahashi M. Protective effect of immediate inoculation of a live varicella vaccine in household contacts in relation to the viral dose and interval between exposure and vaccination. Biken J 25 (1982) 43-45
11. Asano Y., Albrecht P., Vujcic L.K., Quinnan Jr. G.V., Kawakami K., and Takahashi M. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays. Pediatrics 72 (1983) 291-294
12. Ozaki T., Matsui T., Ichikawa T., Asano Y., Yamanishi K., and Takahashi M. Clinical trials of the OKA strain of live attenuated varicella vaccine for healthy children. Biken J 27 (1984) 39-42
13. Asano Y., Nagai T., Miyata T., Yazaki T., Ito S., Yamanishi K., et al. Persistence of protective immunity after inoculation with live varicella vaccine (Strain OKA). Biken J 27 (1984) 123-128
14. Asano Y., Nagai T., Miyata T., Yazaki T., Ito S., Yamanishi K., et al. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine. Pediatrics 75 (1985) 667-671
15. Asano Y., Suga S., Yoshikawa T., Kobayashi I., Yazaki T., Shibata M., et al. Twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics 94 4 (1994) 524-526
16. Asano Y. Varicella vaccine: the Japanese experience. J Infect Dis 174 3 (1996) S310-S313
17. Seward J.F., Watson B.M., Peterson C.L., Mascola L., Pelosi J.W., Zhang J.X., et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 287 (2002) 606-611
18. Zhou F., Harpaz R., Jumaan A.O., Winston C.A., and Shefer A. Impact of varicella vaccination on health care utilization. JAMA 294 (2005) 797-802
19. Davis M.M., Patel M.S., and Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 114 (2004) 786-792
20. Nguyen H.Q., Jumaan A.O., and Seward J.F. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 352 (2005) 450-458
21. Staat M.A., Meinzen-Derr J., Welch T., Roberts N.E., Jamison L., Gerber M.A., et al. Varicella-related hospitalization and emergency department visit rates, before and after introduction of varicella vaccine, among white and black children in Hamilton County, Ohio. Pediatrics 117 (2006) e833-e839
22. Kamiya H., Ihara T., Hattori A., Iwasa T., Sakurai M., Izawa T., et al. Diagnostic skin test reactions with varicella virus antigen and clinical application of the test. J Infect Dis 136 6 (1977) 784-788
23. Asano Y., Shiraki K., Takahashi M., Nagai H., Ozaki T., and Yazaki T. Soluble skin test antigen of varicella-zoster virus prepared from the fluid of infected cultures. J Infect Dis 143 (1981) 687-692
24. Takahashi M., Kamiya H., Asano Y., Shiraki K., Baba K., Otsuka T., et al. Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction. Arch Virol 17 (2001) 161-172
25. Takahashi M., Okada S., Miyagawa H., Amo K., Yoshikawa K., Asada H., et al. Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine 21 (2003) 3845-3853
26. Asano Y., Albrecht P., and Vickers J.H. Immunogenicity of wild and attenuated varicella-zoster virus strains in pygmy marmosets. Proc Soc Exp Biol Med 173 (1983) 501-505
27. Asano Y., Albrecht P., Behr D.E., Neff B.J., Vickers J.H., and Rastogi S.C. Immunogenicity of wild and attenuated varicella-zoster virus strains in rhesus monkeys. J Med Virol 14 (1984) 305-312
28. Grose C. Variation of theme by Fenner: the pathogenesis of chickenpox. Pediatrics 68 (1981) 735-737
29. Ozaki T., Ichikawa T., Matsui Y., Nagai T., Asano Y., Yamanishi K., et al. Viremic phase in nonimmunocompromized children with varicella. J Pediatr 104 (1984) 85-87
30. Asano Y., Itakura N., Hiroishi Y., Hirose S., Nagai T., Ozaki T., et al. Viremia is present in incubation period in nonimmunocompromised children with varicella. J Pediatr 106 1 (1985) 69-71
31. Asano Y., Itakura N., Hiroishi Y., Hirose S., Ozaki T., Kuno K., et al. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J Infect Dis 152 (1985) 863-868
32. Ozaki T., Ichikawa T., Matsui Y., Kondo H., Nagai T., Asano Y., et al. Lymphocyte-associated viremia in varicella. J Med Virol 19 (1986) 249-253
33. Ozaki T., Kajita Y., Asano Y., Aono T., and Yamanishi K. Detection of varicella-zoster virus DNA in blood of children with varicella. J Med Virol 44 (1994) 263-265
34. Asano Y., Yoshikawa T., Urisu A., Yazaki T., Mizoguchi Y., and Kurata T. Varicella-zoster virus replication site in internal organs of an otherwise healthy child with varicella and sudden death. Acta Paediatr Jpn 35 (1993) 348-351
35. Asano Y., Itakura N., Kajita Y., Suga S., Yoshikawa T., Yazaki T., et al. Severity of viremia and clinical findings in children with varicella. J Infect Dis 161 (1990) 1095-1098
36. Ozaki T., Masuda S., Asano Y., Kondo K., Namazue J., and Yamanishi K. Investigation of varicella-zoster virus DNA by the polymerase chain reaction in healthy children with varicella vaccination. J Med Virol 42 (1994) 47-51
37. Ozaki T., Matsui Y., Asano Y., Okuno T., Yamanishi K., and Takahashi M. Study of virus isolation from pharyngeal swabs in children with varicella. Am J Dis Child 143 (1989) 1448-1450
38. Asano Y., Yoshikawa T., Ihira M., Furukawa H., Suzuki K., and Suga S. Spread of varicella-zoster virus DNA to family members and environments from siblings with varicella in a household. Pediatrics 103 5 (1999) e61
39. Suzuki K., Yoshikawa T., Ihira M., Ohashi M., Suga S., and Asano Y. Spread of varicella-zoster virus DNA to the environment from varicella patients who were treated with oral acyclovir. Pediatr Int 45 4 (2003) 458-460
40. Yoshikawa T., Ihira M., Suzuki K., Suga S., Tomitaka A., Ueda H., et al. Rapid contamination of the environments with varicella-zoster virus DNA from a patients with herpes zoster. J Med Virol 63 (2001) 64-66
41. Suzuki K., Yoshikawa T., Tomitaka A., Suzuki K., Matsunaga K., and Asano Y. Detection of varicella-zoster virus DNA in throat swabs of patients with herpes zoster and on air purifier filters. J Med Virol 66 4 (2002) 567-570
42. Suzuki K., Yoshikawa T., Tomitaka A., Matsunaga K., and Asano Y. Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster. J Infect Dis 189 (2004) 1009-1012
43. Asano Y., Yoshikawa T., Suga S., Kobayashi I., Nakashima T., Yazaki T., et al. Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 92 (1993) 219-222
44. Suga S., Yoshikawa T., Ozaki T., and Asano Y. Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella. Arch Dis Child 69 (1993) 639-643
45. Asano Y., Suga S., Yoshikawa T., and Ozaki T. Prophylaxis or modification of varicella by oral acyclovir after household exposure. Arch Dis Child 70 (1994) 451-452
46. Asano Y., Suga S., and Yoshikawa T. Comparison of specific immunities to varicella-zoster virus following post-exposure prophylaxis of varicella by oral acyclovir observed in a family. Acta Paediatr Jpn 38 6 (1996) 692-694
47. Suga S., Yoshikawa T., Yazaki T., Ozaki T., and Asano Y. Dose-dependent effects of oral acyclovir in the incubation period of varicella. Acta Paediatr 85 12 (1996) 1418-1421
48. Yoshikawa T., Suga S., Kozawa T., Kawaguchi S., and Asano Y. Persistence of protective immunity after postexposure prophylaxis of varicella with oral acyclovir in the family setting. Arch Dis Child 78 (1998) 61-63